Neutrophilic skin or joint disease favors assessment with IL-17/23 panels, while crystal arthropathies or recurrent inflammatory flares warrant IL-1β, urate, and NLRP3 inflammasome profiling. This evidence concerns the gene NLRP3 and arthropathy.